Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a top… Read more
Journey Medical Corp (DERM) - Total Liabilities
Latest total liabilities as of September 2025: $59.29 Million USD
Based on the latest financial reports, Journey Medical Corp (DERM) has total liabilities worth $59.29 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Journey Medical Corp - Total Liabilities Trend (2014–2024)
This chart illustrates how Journey Medical Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Journey Medical Corp Competitors by Total Liabilities
The table below lists competitors of Journey Medical Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
lastminute.com N.V
PINK:LSMNF
|
USA | $424.30 Million |
|
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671
|
China | CN¥335.43 Million |
|
United Pharm
KO:033270
|
Korea | ₩64.04 Billion |
|
Cool Company Oy
OL:CLCO
|
Norway | Nkr1.53 Billion |
|
Angel Oak Mortgage Inc
NYSE:AOMR
|
USA | $2.48 Billion |
|
Carbios
PA:ALCRB
|
France | €65.53 Million |
|
Stereotaxis Inc
NYSE MKT:STXS
|
USA | $34.05 Million |
Liability Composition Analysis (2014–2024)
This chart breaks down Journey Medical Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.42 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.29 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.70 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Journey Medical Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Journey Medical Corp (2014–2024)
The table below shows the annual total liabilities of Journey Medical Corp from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $60.17 Million | +6.50% |
| 2023-12-31 | $56.50 Million | -35.93% |
| 2022-12-31 | $88.18 Million | +59.62% |
| 2021-12-31 | $55.24 Million | +32.75% |
| 2020-12-31 | $41.61 Million | +33.78% |
| 2019-12-31 | $31.11 Million | -91.20% |
| 2018-12-31 | $353.36 Million | -14.05% |
| 2017-12-31 | $411.14 Million | +530.29% |
| 2016-12-31 | $65.23 Million | +78.93% |
| 2015-12-31 | $36.46 Million | +47.95% |
| 2014-12-31 | $24.64 Million | -- |